Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinastine Nasal Spray in Seasonal Allergic Rhinitis
NCT00407927Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epinastine in seasonal allergic rhinitis (SAR), sponsored by Merck & Co.. Started Dec 2006; status: completed.
02
Drugs
epinastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00407927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407927.